{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:40:41Z","timestamp":1789767641865,"version":"4.0.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T00:00:00Z","timestamp":1696809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T00:00:00Z","timestamp":1696809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s10585-023-10236-4","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T10:04:45Z","timestamp":1696845885000},"page":"505-515","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["High sensitivity flow cytometry immunophenotyping increases the diagnostic yield of malignant pleural effusions"],"prefix":"10.1007","volume":"40","author":[{"given":"Dolores","family":"Subir\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola","family":"Barriopedro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Chara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Castelao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,9]]},"reference":[{"key":"10236_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1183\/13993003.01254-2018","volume":"52","author":"DT Arnold","year":"2018","unstructured":"Arnold DT, Fonseka D, De, Perry S, Morley A, Harvey JE, Medford A, Brett M, Maskell NA (2018) Investigating unilateral pleural effusions: the role of cytology. Eur Respir J 52:1\u20139. https:\/\/doi.org\/10.1183\/13993003.01254-2018","journal-title":"Eur Respir J"},{"key":"10236_CR2","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.21037\/tlcr-20-1111","volume":"10","author":"M Zhang","year":"2021","unstructured":"Zhang M, Yan L, Lippi G, Hu Z, De (2021) Pleural biomarkers in diagnostics of malignant pleural effusion: a narrative review. Translational Lung Cancer Research 10:1557\u20131570. https:\/\/doi.org\/10.21037\/tlcr-20-1111","journal-title":"Translational Lung Cancer Research"},{"key":"10236_CR3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000481290","volume":"95","author":"G Dixon","year":"2018","unstructured":"Dixon G, Bhatnagar R, Zahan-Evans N, Clive AO, Virgo PF, Brett MT, Otton SH, Medford ARL, Maskell NA (2018) A prospective study to evaluate a diagnostic algorithm for the use of fluid lymphocyte subset analysis in undiagnosed unilateral pleural effusions. Respiration 95:98\u2013105. https:\/\/doi.org\/10.1159\/000481290","journal-title":"Respiration"},{"key":"10236_CR4","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1309\/FU3FDKYN8AU0891N","volume":"119","author":"A Chang","year":"2003","unstructured":"Chang A, Benda PM, Wood BL, Kussick SJ (2003) Lineage-specific identification of nonhematopoietic neoplasms by flow cytometry. Am J Clin Pathol 119:643\u2013655. https:\/\/doi.org\/10.1309\/FU3FDKYN8AU0891N","journal-title":"Am J Clin Pathol"},{"key":"10236_CR5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/cyto.b.21258","volume":"90","author":"M Acosta","year":"2016","unstructured":"Acosta M, Pereira J, Arroz M (2016) Screening of carcinoma metastasis by flow cytometry: a study of 238 cases. Cytometry part B -. Clin Cytometry 90:289\u2013294. https:\/\/doi.org\/10.1002\/cyto.b.21258","journal-title":"Clin Cytometry"},{"key":"10236_CR6","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/cyto.b.21886","volume":"98","author":"J Wong-Arteta","year":"2020","unstructured":"Wong-Arteta J, Rey M, Arag\u00f3n L, Gil-Rodr\u00edguez E, Bujanda L (2020) The utility of flow cytometry in the diagnostic work up of malignant effusions due to nonhematopoietic neoplasms. Cytometry part B -. Clin Cytometry 98:504\u2013515. https:\/\/doi.org\/10.1002\/cyto.b.21886","journal-title":"Clin Cytometry"},{"key":"10236_CR7","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1309\/AJCP4HIFSHMO9WTK","volume":"139","author":"V Pillai","year":"2013","unstructured":"Pillai V, Cibas ES, Dorfman DM (2013) A simplified flow cytometric immunophenotyping procedure for the diagnosis of effusions caused by epithelial malignancies. Am J Clin Pathol 139:672\u2013681. https:\/\/doi.org\/10.1309\/AJCP4HIFSHMO9WTK","journal-title":"Am J Clin Pathol"},{"key":"10236_CR8","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/cyto.b.20608","volume":"80 B","author":"NA Kentrou","year":"2011","unstructured":"Kentrou NA, Tsagarakis NJ, Tzanetou K, Damala M, Papadimitriou KA, Skoumi D, Stratigaki A, Anagnostopoulos NI, Malamou-Lada E, Athanassiadou P, Paterakis G (2011) An improved flow cytometric assay for detection and discrimination between malignant cells and atypical mesothelial cells, in serous cavity effusions. Cytometry Part B - Clinical Cytometry 80 B:324\u2013334. https:\/\/doi.org\/10.1002\/cyto.b.20608","journal-title":"Cytometry Part B - Clinical Cytometry"},{"key":"10236_CR9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/cyt.12922","volume":"32","author":"S Sahu","year":"2021","unstructured":"Sahu S, Gupta P, Susheilia S, Gautam U, Dey P (2021) Application of multicolour flow cytometry in the detection of metastatic carcinoma in serous effusions: special emphasis in atypical cytology. Cytopathology 32:169\u2013179. https:\/\/doi.org\/10.1111\/cyt.12922","journal-title":"Cytopathology"},{"key":"10236_CR10","doi-asserted-by":"publisher","unstructured":"Quir\u00f3s-Caso C, Arias Fern\u00e1ndez T, Fonseca-Mourelle A, Torres H, Fern\u00e1ndez L, Moreno-Rodr\u00edguez M, Ariza-Prota M\u00c1, L\u00f3pez-Gonz\u00e1lez FJ, Carvajal-\u00c1lvarez M, Alonso-\u00c1lvarez S, Moro-Garc\u00eda MA, Colado E (2022) Routine flow cytometry approach for the evaluation of solid tumor neoplasms and immune cells in minimally invasive samples. Cytometry Part B - Clinical Cytometry 1\u201311. https:\/\/doi.org\/10.1002\/cyto.b.22081","DOI":"10.1002\/cyto.b.22081"},{"key":"10236_CR11","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1136\/jcp.53.7.513","volume":"53","author":"B Risberg","year":"2000","unstructured":"Risberg B, Davidson B, Dong HP, Nesland JM, Berner A (2000) Flow cytometric immunophenotyping of serous effusions and peritoneal washings: comparison with immunocytochemistry and morphological findings. J Clin Pathol 53:513\u2013517. https:\/\/doi.org\/10.1136\/jcp.53.7.513","journal-title":"J Clin Pathol"},{"key":"10236_CR12","doi-asserted-by":"publisher","unstructured":"Hooper C, Lee YCG, Maskell N, Pleural BTS (2010) Investigation of a unilateral pleural effusion in adults : british thoracic society pleural disease guideline 2010. 65. https:\/\/doi.org\/10.1136\/thx.2010.136978","DOI":"10.1136\/thx.2010.136978"},{"key":"10236_CR13","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jasc.2020.05.015","volume":"9","author":"D Pinto","year":"2020","unstructured":"Pinto D, Chandra A, Crothers BA, Kurtycz DFI, Schmitt F (2020) The international system for reporting serous fluid cytopathology\u2014diagnostic categories and clinical management. J Am Soc Cytopathol 9:469\u2013477. https:\/\/doi.org\/10.1016\/j.jasc.2020.05.015","journal-title":"J Am Soc Cytopathol"},{"key":"10236_CR14","doi-asserted-by":"publisher","unstructured":"Samper GJ, Herrera S, Estrella L, Marco J, Rafael B, Lapiedra A, Pinilla A (2017) Predicting Malignant and Paramalignant Pleural Effusions by combining Clinical, Radiological and Pleural Fluid Analytical Parameters. 653\u2013660. https:\/\/doi.org\/10.1007\/s00408-017-0032-3","DOI":"10.1007\/s00408-017-0032-3"},{"key":"10236_CR15","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1038\/leu.2012.120","volume":"26","author":"JJM van Dongen","year":"2012","unstructured":"van Dongen JJM, Lhermitte L, B\u00f6ttcher S, van der Almeida J, Flores-Montero J, Rawstron A, Asnafi V, L\u00e9crevisse Q, Lucio P, Mejstrikova E, Szczepa\u0144ski T, Kalina T, de Tute R, Br\u00fcggemann M, Sedek L, Cullen M, Langerak AW, Mendon\u00e7a A, Macintyre E, Martin-Ayuso M, Hrusak O, Vidriales MB, Orfao A (2012) EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes. Leukemia 26:1908\u20131975. https:\/\/doi.org\/10.1038\/leu.2012.120","journal-title":"Leukemia"},{"key":"10236_CR16","doi-asserted-by":"publisher","first-page":"112684","DOI":"10.1016\/j.jim.2019.112684","volume":"475","author":"A Orfao","year":"2019","unstructured":"Orfao A, Matarraz S, P\u00e9rez-Andr\u00e9s M, Almeida J, Teodosio C, Berkowska MA, van Dongen JJM (2019) Immunophenotypic dissection of normal hematopoiesis. J Immunol Methods 475:112684. https:\/\/doi.org\/10.1016\/j.jim.2019.112684","journal-title":"J Immunol Methods"},{"key":"10236_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/cyto.b.21228","volume":"90","author":"M Arroz","year":"2016","unstructured":"Arroz M, Came N, Lin P, Chen W, Yuan C, Lagoo A, Monreal M, de Tute R, Vergilio JA, Rawstron AC, Paiva B (2016) Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting. Cytometry part B -. Clin Cytometry 90:31\u201339. https:\/\/doi.org\/10.1002\/cyto.b.21228","journal-title":"Clin Cytometry"},{"key":"10236_CR18","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1159\/000448371","volume":"60","author":"V Pillai","year":"2016","unstructured":"Pillai V, Dorfman DM (2016) Flow cytometry of nonhematopoietic neoplasms. Acta Cytol 60:336\u2013343. https:\/\/doi.org\/10.1159\/000448371","journal-title":"Acta Cytol"},{"key":"10236_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","volume":"142","author":"AN Husain","year":"2018","unstructured":"Husain AN, Colby TV, Ord\u00f3\u00f1ez NG, Allen TC, Attanoos RL, Beasley MB, Butnor KJ, Chirieac LR, Churg AM, Dacic S, Galateau-Sall\u00e9 F, Gibbs A, Gown AM, Krausz T, Litzky LA, Marchevsky A, Nicholson AG, Roggli VL, Sharma AK, Travis WD, Walts AE, Wick MR (2018) Guidelines for pathologic diagnosis of malignant mesothelioma: 2017 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med 142:89\u2013108. https:\/\/doi.org\/10.5858\/arpa.2017-0124-RA","journal-title":"Arch Pathol Lab Med"},{"key":"10236_CR20","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.patol.2020.04.005","volume":"54","author":"C del D\u00edaz","year":"2021","unstructured":"del D\u00edaz C, Saiz-Pardo Sanz M, Ortega Medina L, Fern\u00e1ndez Ace\u00f1ero MJ (2021) Ber-EP4 staining in effusion cytology: a potential source of false positives. Revista Esp de Patologia 54:114\u2013122. https:\/\/doi.org\/10.1016\/j.patol.2020.04.005","journal-title":"Revista Esp de Patologia"},{"key":"10236_CR21","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1046\/j.1365-2559.2003.01686.x","volume":"43","author":"RL Attanoos","year":"2003","unstructured":"Attanoos RL, Griffin A, Gibbs AR (2003) The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2. Histopathology 43:231\u2013238. https:\/\/doi.org\/10.1046\/j.1365-2559.2003.01686.x","journal-title":"Histopathology"},{"key":"10236_CR22","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/dc.2840100207","volume":"10","author":"B Maguire","year":"1994","unstructured":"Maguire B, Whitaker D, Carrello S, Spagnolo D (1994) Monoclonal antibody Ber-EP4: its use in the differential diagnosis of malignant mesothelioma and carcinoma in cell blocks of malignant effusions and FNA specimens. Diagn Cytopathol 10:130\u2013134","journal-title":"Diagn Cytopathol"},{"key":"10236_CR23","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1007\/s00428-021-03077-7","volume":"479","author":"T Salisbury","year":"2021","unstructured":"Salisbury T, Churg A (2021) CD146 immunohistochemical staining for the separation of benign from malignant mesothelial proliferations. Virchows Arch 479:1047\u20131050","journal-title":"Virchows Arch"},{"key":"10236_CR24","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1038\/modpathol.2010.134","volume":"23","author":"A Sato","year":"2010","unstructured":"Sato A, Torii I, Okamura Y, Yamamoto T, Nishigami T, Kataoka TR, Song M, Hasegawa S, Nakano T, Kamei T, Tsujimura T (2010) Immunocytochemistry of CD146 is useful to discriminate between malignant pleural mesothelioma and reactive mesothelium. Mod Pathol 23:1458\u20131466. https:\/\/doi.org\/10.1038\/modpathol.2010.134","journal-title":"Mod Pathol"},{"key":"10236_CR25","doi-asserted-by":"publisher","first-page":"e328","DOI":"10.1016\/S1470-2045(16)30206-6","volume":"17","author":"S Kumar","year":"2016","unstructured":"Kumar S, Paiva B, Anderson KC, Durie B, Landgren O, Moreau P, Munshi N, Lonial S, Blad\u00e9 J, Mateos MV, Dimopoulos M, Kastritis E, Boccadoro M, Orlowski R, Goldschmidt H, Spencer A, Hou J, Chng WJ, Usmani SZ, Zamagni E, Shimizu K, Jagannath S, Johnsen HE, Terpos E, Reiman A, Kyle RA, Sonneveld P, Richardson PG, McCarthy P, Ludwig H, Chen W, Cavo M, Harousseau JL, Lentzsch S, Hillengass J, Palumbo A, Orfao A, Rajkumar SV, Miguel JS, Avet-Loiseau H (2016) International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol 17:e328\u2013e346. https:\/\/doi.org\/10.1016\/S1470-2045(16)30206-6","journal-title":"Lancet Oncol"},{"key":"10236_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.lungcan.2018.11.020","volume":"127","author":"JC Thompson","year":"2019","unstructured":"Thompson JC, Fan R, Black T, Yu GH, Savitch SL, Chien A, Yee SS, Sen M, Hwang WT, Katz SI, Feldman M, Vachani A, Carpenter EL (2019) Measurement and immunophenotyping of pleural fluid EpCAM-positive cells and clusters for the management of non-small cell lung cancer patients. Lung Cancer 127:25\u201333. https:\/\/doi.org\/10.1016\/j.lungcan.2018.11.020","journal-title":"Lung Cancer"},{"key":"10236_CR27","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jasc.2016.07.001","volume":"5","author":"MY Fuller","year":"2016","unstructured":"Fuller MY, Thrall MJ (2016) Utility of flow cytometry analysis for pleural and peritoneal fluids. J Am Soc Cytopathol 5:339\u2013344. https:\/\/doi.org\/10.1016\/j.jasc.2016.07.001","journal-title":"J Am Soc Cytopathol"},{"key":"10236_CR28","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.jasc.2020.07.131","volume":"9","author":"RM Plummer","year":"2020","unstructured":"Plummer RM, Kelting S, Madan R, O\u2019Neil M, Dennis K, Fan F (2020) Triaging of pleural effusion cytology specimens for ancillary flow cytometric analysis. J Am Soc Cytopathol 9:478\u2013484. https:\/\/doi.org\/10.1016\/j.jasc.2020.07.131","journal-title":"J Am Soc Cytopathol"},{"key":"10236_CR29","doi-asserted-by":"publisher","first-page":"81558","DOI":"10.18632\/oncotarget.18277","volume":"8","author":"XX Jie","year":"2017","unstructured":"Jie XX, Zhang XY, Xu CJ (2017) Epithelial-to-mesenchymal transition, circulating tumor cells and cancer metastasis: mechanisms and clinical applications. Oncotarget 8:81558\u201381571. https:\/\/doi.org\/10.18632\/oncotarget.18277","journal-title":"Oncotarget"},{"key":"10236_CR30","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1136\/jcp.2011.090274","volume":"64","author":"G Spizzo","year":"2011","unstructured":"Spizzo G, Fong D, Wurm M, Ensinger C, Obrist P, Hofer C, Mazzoleni G, Gastl G, Went P (2011) EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis. J Clin Pathol 64:415\u2013420. https:\/\/doi.org\/10.1136\/jcp.2011.090274","journal-title":"J Clin Pathol"},{"key":"10236_CR31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1309\/M877-QABM-D9GB-FJAX","volume":"118","author":"B Davidson","year":"2002","unstructured":"Davidson B, Dong HP, Berner A, Christensen J, Nielsen S, Johansen P, Bryne M, Asschenfeldt P, Risberg B (2002) Detection of malignant epithelial cells in effusions using flow cytometric immunophenotyping: an analysis of 92 cases. Am J Clin Pathol 118:85\u201392. https:\/\/doi.org\/10.1309\/M877-QABM-D9GB-FJAX","journal-title":"Am J Clin Pathol"},{"key":"10236_CR32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.lungcan.2020.07.013","volume":"148","author":"JY Yoon","year":"2020","unstructured":"Yoon JY, Nayyar R, Quest G, Pabedinskas D, Pal P, Tsao MS, Schwock J, Ko HM (2020) PD-L1 lineage-specific quantification in malignant pleural effusions of lung adenocarcinoma by flow cytometry. Lung Cancer 148:55\u201361. https:\/\/doi.org\/10.1016\/j.lungcan.2020.07.013","journal-title":"Lung Cancer"},{"key":"10236_CR33","doi-asserted-by":"publisher","unstructured":"De S\u00e1 Ferreira-Facio C, Botafogo V, Ferr\u00e3o PM, Canellas MC, Milito CB, Romano S, Lopes DV, Teixeira LC, Oliveira E, Bruno-Riscarolli E, Mello FV, Siqueira PFR, Moura P, Macedo FN, Forny DN, Simi\u00e3o L, Pureza AL, Poirot Land MG, Pedreira CE, Van Dongen JJM, Orfao A, Da Costa ES (2021) Flow cytometry immunophenotyping for diagnostic orientation and classification of pediatric cancer based on the euroflow solid tumor orientation tube (stot). Cancers 13. https:\/\/doi.org\/10.3390\/cancers13194945","DOI":"10.3390\/cancers13194945"}],"container-title":["Clinical &amp; Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-023-10236-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10585-023-10236-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-023-10236-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T10:09:53Z","timestamp":1698746993000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10585-023-10236-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,9]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10236"],"URL":"https:\/\/doi.org\/10.1007\/s10585-023-10236-4","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,9]]},"assertion":[{"value":"2 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that no funds, grants, or other support were received during the preparation of this manuscript. The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}